Your search returned 13 studies. (Get alerts for new studies):
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Conditions: brca1 Mutation Carrier - Breast Cancer
3 Locations available
- ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Pancreatic Cancer - Peritoneal Cavity Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Pr
1 Location available
- Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
1 Location available
- Impact of Testing Positive for the BRCA1 or BRCA2 Mutation in Young Women Who Are BRCA1 or BRCA2 Mutation Carriers
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Sexuality and Reproductive Issues
1 Location available
- Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Ovarian Cancer
1 Location available
- High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
134 Locations available
- Veliparib With or Without Carboplatin in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
20 Locations available
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Ductal Breast Carcinoma in Situ - Lobular Breast Carcinoma in Situ - Stage IA Breast Cancer - Stage IB Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer
1 Location available
- Veliparib and Dinaciclib With or Without Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
30 Locations available
|